Published in Cancer Weekly, November 5th, 2002
Researchers set out to discover whether the most aggressive, high-risk squamous cell carcinoma patients who had their cancers surgically removed were less likely to have local or regional recurrence of the disease if the chemotherapy drug cisplatin was given concurrently with postoperative radiation therapy.
A total of 459 patients were enrolled in the study. Patients...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.